Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Leuk Lymphoma. 2014 Oct 30;56(6):1665–1670. doi: 10.3109/10428194.2014.963078

Figure 2.

Figure 2

Event-free (a, c) and overall (b, d) survival of limited stage PTCL (PTCL-NOS, AITL, ALCL) patients who received front-line combination chemotherapy with (—) or without (·····) radiotherapy. A landmark analysis, including those who achieved a complete or partial remission following front-line combination chemotherapy, is shown (c, d).